• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
VRAY

VRAY

ViewRay, Inc.

NASDAQHealthcareMedical - DevicesUS

USD0.03

+0.00 (+0.00%)

Company Profile

CEO

Paul Ziegler Jr.,

IPO Date

2015-08-10

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.04

Prev. Close

$0.03

Day Low

$0.02

Day High

$0.04

52W Low

$0.02

52W High

$0.04

Market Cap

$0.00B

Volume

96.17M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

45.6%

Avg Negative

2.7%

Avg Neutral

52.0%

News Feed

ViewRay Announces Conference Call for Second Quarter 2021 Financial Results to be Held After Market on August 5, 2021

PRNewsWire·7/15/2021·↓ negative

Miami Cancer Institute Enrolls First Patients in Single-Fraction Stereotactic MRI-Guided Adaptive Radiation Therapy for Inoperable Primary or Metastatic Cancer Trial

PRNewsWire·7/7/2021·↑ positive

GenesisCare Expands their MR-guided Radiotherapy Reach with the Purchase of Multiple MRIdian® Systems

PRNewsWire·6/24/2021·↑ positive

Cancer Patients Across the U.S. to Benefit from GenesisCare's Partnership with ViewRay, Inc.

PRNewsWire·6/24/2021·↑ positive

ViewRay Announces Election of Karen N. Prange to its Board of Directors

PRNewsWire·6/11/2021·↑ positive

Strength Seen in ViewRay (VRAY): Can Its 13.8% Jump Turn into More Strength?

Zacks Investment Research·5/10/2021·↑ positive

ViewRay, Inc. (VRAY) CEO Scott Drake on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

Why ViewRay Stock Vaulted Higher Today

The Motley Fool·5/7/2021·↑ positive

VRAY Stock: Over 5% Increase Pre-Market Explanation

Pulse2·5/7/2021·↑ positive

ViewRay (VRAY) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/6/2021·↑ positive